Applied DNA Sciences (APDN) Misses Q3 EPS by 3c

Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.10), $0.03 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $2.61 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• L3Harris CEO steps down amid conduct review, shares drop